Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / American Depositary Shares, each representing 1 Ordinary Shares
-
Shares outstanding
-
100M
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
10.6M
-
Shares change
-
-1.48M
-
Total reported value, excl. options
-
$30.1M
-
Value change
-
-$4.7M
-
Number of buys
-
12
-
Number of sells
-
-27
-
Price
-
$2.83
Significant Holders of Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) as of Q2 2022
52 filings reported holding CLLS - Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares as of Q2 2022.
Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.6M shares
of 100M outstanding shares and own 10.61% of the company stock.
Largest 10 shareholders include Long Focus Capital Management, LLC (2.79M shares), CREDIT SUISSE AG/ (1.44M shares), PRINCIPAL FINANCIAL GROUP INC (1.35M shares), BAILLIE GIFFORD & CO (881K shares), Capital International Investors (581K shares), JANE STREET GROUP, LLC (490K shares), MILLENNIUM MANAGEMENT LLC (453K shares), Bpifrance SA (426K shares), BlackRock Inc. (290K shares), and Hudson Bay Capital Management LP (275K shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.